IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MARZANO, ANGELO VALERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 26.992
AS - Asia 25.565
NA - Nord America 22.045
SA - Sud America 4.030
AF - Africa 908
OC - Oceania 339
Continente sconosciuto - Info sul continente non disponibili 23
Totale 79.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.467
CN - Cina 7.681
IT - Italia 7.575
SG - Singapore 6.381
GB - Regno Unito 5.040
IN - India 2.920
DE - Germania 2.742
BR - Brasile 2.465
HK - Hong Kong 1.715
ES - Italia 1.694
TR - Turchia 1.587
RU - Federazione Russa 1.459
SE - Svezia 1.284
FR - Francia 1.276
JP - Giappone 1.123
NL - Olanda 949
VN - Vietnam 833
CA - Canada 710
IE - Irlanda 694
ID - Indonesia 671
MX - Messico 667
KR - Corea 580
FI - Finlandia 578
CO - Colombia 486
PL - Polonia 471
AR - Argentina 441
UA - Ucraina 440
CH - Svizzera 374
GR - Grecia 332
DK - Danimarca 328
BE - Belgio 316
PT - Portogallo 300
AU - Australia 290
TW - Taiwan 276
TH - Thailandia 249
AT - Austria 237
CI - Costa d'Avorio 230
CL - Cile 226
SA - Arabia Saudita 208
EU - Europa 180
MY - Malesia 160
PE - Perù 159
RO - Romania 156
PH - Filippine 143
ZA - Sudafrica 138
IR - Iran 137
IL - Israele 136
EG - Egitto 123
BD - Bangladesh 119
HU - Ungheria 107
PK - Pakistan 103
TN - Tunisia 98
MA - Marocco 96
CZ - Repubblica Ceca 95
EC - Ecuador 88
IQ - Iraq 81
BG - Bulgaria 77
AE - Emirati Arabi Uniti 73
LT - Lituania 73
RS - Serbia 62
HR - Croazia 61
SI - Slovenia 57
VE - Venezuela 55
UY - Uruguay 52
NP - Nepal 50
ET - Etiopia 45
NZ - Nuova Zelanda 43
SK - Slovacchia (Repubblica Slovacca) 42
CR - Costa Rica 39
DZ - Algeria 38
KE - Kenya 38
UZ - Uzbekistan 38
KW - Kuwait 32
BO - Bolivia 29
NO - Norvegia 29
PA - Panama 28
KZ - Kazakistan 26
PY - Paraguay 26
GE - Georgia 25
JO - Giordania 25
SV - El Salvador 25
DO - Repubblica Dominicana 22
CY - Cipro 21
AZ - Azerbaigian 20
BH - Bahrain 20
EE - Estonia 20
LB - Libano 20
QA - Qatar 19
BY - Bielorussia 18
LK - Sri Lanka 18
LU - Lussemburgo 17
AL - Albania 16
LV - Lettonia 16
GT - Guatemala 15
MK - Macedonia 15
MT - Malta 15
NG - Nigeria 14
SN - Senegal 14
OM - Oman 13
PR - Porto Rico 13
Totale 79.828
Salva come PNG Salva come JPEG
Città #
Southend 3.405
Singapore 2.982
Ashburn 2.232
Milan 1.772
Hong Kong 1.325
Dallas 1.242
Beijing 1.214
Chandler 1.072
Hefei 1.025
Dublin 671
Los Angeles 664
Bengaluru 660
Fairfield 651
Frankfurt am Main 634
Seattle 627
Princeton 599
Wilmington 568
Council Bluffs 551
Ann Arbor 502
Istanbul 470
New York 429
Madrid 420
Santa Clara 407
Tokyo 401
Rome 391
Redwood City 390
Houston 384
Jakarta 379
Woodbridge 378
Guangzhou 374
Shanghai 371
San Jose 359
Buffalo 318
São Paulo 317
Ho Chi Minh City 306
Jacksonville 297
Barcelona 293
Helsinki 293
Nanjing 291
Moscow 283
Cambridge 242
Des Moines 239
Bogotá 236
London 232
Munich 232
Ankara 230
Abidjan 229
Boardman 226
Chicago 218
Mountain View 198
Seoul 198
Warsaw 198
Mumbai 196
Toronto 191
Delhi 184
Redmond 178
Chennai 177
Berlin 176
Florence 174
Hanover 172
Hanoi 170
Athens 167
Buenos Aires 158
Paris 158
Hangzhou 156
New Delhi 153
Taipei 149
Bangkok 145
Dearborn 144
Rio de Janeiro 143
Brussels 142
Bologna 141
Cangzhou 138
Phoenix 136
Santiago 136
Serra 130
Vienna 130
Amsterdam 129
Hyderabad 126
Reston 126
Turin 125
Riyadh 123
Izmir 119
Medellín 119
Nuremberg 119
Pune 119
Naples 116
Valencia 116
Lima 114
Zurich 112
Hamburg 109
Boston 108
Montreal 107
Chengdu 106
Fuzhou 106
Columbus 104
Shenyang 104
Mexico City 100
San Diego 100
Tianjin 100
Totale 39.176
Salva come PNG Salva come JPEG
Nome #
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) 5.165
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum : A Delphi Consensus of International Experts 3.963
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) 3.840
Evidence for a “window of opportunity” in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicenter cohort study 2.694
What causes hidradenitis suppurativa ? - 15 years after 1.314
Comparison of clinical and sonographic scores in hidradenitis suppurativa and proposal of a novel ultrasound scoring system 1.067
Target molecules for future hidradenitis suppurativa treatment 1.029
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 974
Cheratosi lichenoide cronica e cheratoacantomi eruttivi in una paziente con mieloma multiplo 828
Scleromixedema 798
Pustolosi amicrobica delle pieghe 791
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment 653
Photobiomodulation as potential novel third line tool for non-invasive treatment of Hidradenitis Suppurativa 641
Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils 607
Pyoderma gangrenosum : proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1 606
New validated diagnostic criteria for pyoderma gangrenosum 592
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review 568
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib 546
RESISTENZE CLINICHE ALLA TERBINAFINA IN CEPPI DI Trichophyton rubrum E indotinae ISOLATI IN ITALIA: PRESENTAZIONE CLINICA, SUSCETTIBILITA’ ANTIMICOTICA E MUTAZIONI DEL GENE SQUALENE EPOSSIDASI 491
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa 476
Increased risk of venous thromboembolism in patients with bullous pemphigoid : the INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study 451
Il pioderma gangrenoso: nuovi aspetti clinici e patogenetici 372
S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology 368
Clinical and immunopathological features of idiopathic cutaneous IgM/IgG vasculitis versus idiopathic skin-limited IgA vasculitis 368
Report of terbinafine resistant Trichophyton spp. in Italy: Clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene 354
The influence of genetic variations on activation of blood coagulation: a possible explanations for the increased thrombotic risk in bullous pemphigoid 352
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 314
Dermoscopic predictors of melanoma in small diameter melanocytic lesions (mini-melanoma): a retrospective multicentric study of 269 cases 306
Autoantibody profile of a cohort of 78 Italian patients with mucous membrane pemphigoid: correlation between reactivity profile and clinical involvement 302
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV) 256
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases 256
Vasculite gangrenosa giovanile dello scroto 255
Pancreatic panniculitis : the "bright" side of the moon in solid cancer patients 252
Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis 244
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 238
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients 234
Lupus eritematoso profondo 233
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience 227
Pemphigus herpetiformis associated with prostate cancer 226
Activation of blood coagulation in two prototypic autoimmune skin diseases: a possible link with thrombotic risk 224
Molecular and cellular characterization of pyoderma gangrenosum: Implications for the use of gene expression 224
ADHESION MOLECULES, CYTOKINES AND APOPTOSIS IN PSORIASIS 219
Pustolosi amicrobica delle pieghe 217
Management of adult patients with Langerhans cell histiocytosis : recommendations from an expert panel on behalf of Euro-Histio-Net 217
Hidradenitis suppurativa: the "bright side" of autoinflammation and hidden diseases 217
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis : One-Year Experience of 221 Patients 217
Pemfigoide bolloso post-radioterapia 215
Hidradenitis suppurativa and adalimumab in the COVID-19 era 214
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders 213
Skin Manifestations Associated with COVID-19 : Current Knowledge and Future Perspectives 213
Dermoscopy of dermal duct tumour 211
Mixedema pretibiale 210
A unified concept of acne in the papa spectrum disorders 210
Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases 205
Late-onset hidradenitis suppurativa: A cluster analysis of the National Italian Registry IRHIS 205
Post-surgical thyroid bed pyoderma gangrenosum mimicking recurrent papillary thyroid carcinoma 203
A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis 203
De novo annular pustular psoriasis following mRNA COVID-19 vaccine 203
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation 201
Reticular erythematous mucinosis occurring in a brother and sister 199
Il rituximab nella terapia del pemfigo 199
Elephantoid oedema of the eyelids 197
Linear IgA bullous dermatosis in adults and children: A clinical and immunopathological study of 38 patients 197
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients 196
Mycosis fungoides mimicking erythema gyratum repens : an additional variant? 192
Different rates of autoreactivity in patients with recurrent idiopathic angioedema associated or not with wheals 190
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases 190
Co‐occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria 190
Treatment of refractory blistering autoimmune diseases with mychophenolic acid 188
Herpes simplex virus infection and pemphigus 188
Chemotherapeutic experience in indeterminate cell histiocytosis 186
Dermatological Manifestations in Inflammatory Bowel Diseases 186
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria 185
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic 184
Sexualised drug use and chemsex in Italy: A questionnaire study based on a cohort of clients attending a STI outpatient service in Milan 183
Malattia di Letterer-Siwe ad evoluzione infausta in un adulto 183
Vitamin D and skeletal health in autoimmune bullous skin diseases: A case control study 183
Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature 182
Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice 180
Pemfigoide bolloso insorto dopo fototerapia in paziente psoriasico 177
Morbo di Kaposi bolloso 177
Pemfigoide bolloso post-radioterapia 176
Cutaneous manifestations in patients with COVID-19 : a preliminary review of an emerging issue 175
Activation of blood coagulation in bullous pemphigoid : role of eosinophils, and local and systemic implications 174
Amicrobial pustulosis of the folds : report of 6 cases and a literature review 174
Asymptomatic nodule on the upper lip 172
New insights into the pathogenesis of bullous pemphigoid : 2019 update 172
Sindrome di Stevens-Johnson 171
Dermatological disorders 171
Keratosis lichenoides chronica and eruptive keratoacanthoma-like lesions in a patient with multiple myeloma 170
Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (Rituximab) 168
S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV) 168
Attivazione della coagulazione nelle dermatosi bollose autoimmuni 167
Keratosis lichenoides chronica: A case report and focused overview of the literature 167
Neutrophilic and eosinophilic dermatoses associated with hematological malignancy 166
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 166
Eruzione cutanea acneiforme da inibitori del recettore dell'EGF: descrizione di 3 casi 166
Juvenile gangrenous vasculitis of the scrotum: Is it a variant of pyoderma gangrenosum? 165
Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases 165
Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype 165
Totale 44.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 201.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.778
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.972 0 0 0 0 0 0 400 386 521 428 688 549
2021/20226.739 428 425 524 522 577 565 577 542 586 574 428 991
2022/20238.628 723 602 605 693 731 1.113 509 722 910 556 848 616
2023/20249.553 656 845 676 764 1.386 798 690 683 464 687 914 990
2024/202518.791 827 1.354 803 1.601 1.544 1.119 1.353 1.911 1.542 1.662 1.820 3.255
2025/202621.188 3.611 3.068 4.087 3.710 3.561 2.313 838 0 0 0 0 0
Totale 82.866